Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,202 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07689851RecruitingPhase 2
Chemoradiotherapy plus an immunotherapy for advanced gastric cancer
This trial studies a new immunotherapy drug (SHR-1701) combined with standard chemoradiotherapy for people with advanced stomach or esophagus cancer that cannot be surgically removed. The goal is to see if adding this immune treatment helps control the tumor better than standard treatments alone.
Shenzhen, GuangdongAges 18–75 - NCT07688902Recruiting
Comparing two injection methods for partial rotator cuff tears
This study compares two ways of injecting a sugar-water solution (5% dextrose) into the shoulder to treat partial rotator cuff tears. It may help reduce pain and improve shoulder function without surgery.
AnkaraAges 18–75 - NCT07692243Recruiting
Study of nose and sinus tissue differences
This study looks at tissue samples taken during nose or sinus surgery to better understand how these tissues vary. It may help researchers learn more about conditions affecting the nose and sinuses.
Guangzhou, GuangdongAges Any age - NCT07695987Recruiting
Nerve block for pain relief after back surgery
This trial tests a nerve block called Quadro-Iliac Plane Block to reduce pain after a single-level lumbar microdiscectomy (back surgery). The block is given before surgery and may help you need less pain medicine and recover more comfortably.
Istanbul, IstanbulAges 18–75 - NCT07688876Recruiting
Comparing two treatments for long-term heel pain
This trial tests two minimally invasive procedures—pulsed radiofrequency and a dextrose injection—to see which better relieves chronic heel pain from plantar fasciitis that hasn't improved with other treatments.
AnkaraAges 18–70 - NCT07690527Enrolling by invitationPhase 1
Long-term follow-up for RB001 gene therapy in children with Phelan-McDermid syndrome
This study follows children who completed the RB001 gene therapy trial for Phelan-McDermid syndrome (caused by changes in the SHANK3 gene) to monitor their health and progress over a longer period of time.
Beijing, ChinaAges Any age - NCT07691801Recruiting
Testing a New Method to Diagnose a Common Cause of High Blood Pressure
This study uses a new, precise blood test to help diagnose primary aldosteronism, a condition where the adrenal glands make too much of a hormone that raises blood pressure. It compares results from healthy volunteers and patients with suspected primary aldosteronism to see if it works better than current methods.
Beijing, Beijing MunicipalityAges 18–70 - NCT07694674Recruiting
Comparing Biologic Drugs to Prevent Crohn's Return After Surgery
This trial compares different biologic medications to see which best prevents Crohn's disease from coming back after intestinal surgery. It may help you if you have had surgery for Crohn's and are starting a biologic drug soon after.
Shanghai, Shanghai MunicipalityAges 18–85 - NCT07694752Recruiting
MRI study of prostate and urinary sphincter
This study uses special MRI scans to look at the muscle ring that controls urination and the base of the prostate. It may help doctors understand how these areas change with conditions like enlarged prostate or prostate cancer treatment.
Taizhou, JiangsuAges 15–90 - NCT07694921Enrolling by invitation
Non-invasive brain stimulation for Alzheimer's disease
This trial tests if a safe, non-invasive electrical stimulation can help people with Alzheimer's disease. It aims to improve thinking and memory skills.
Hangzhou, ZhejiangAges 60 years+ - NCT07696065RecruitingEarly Phase 1
Palliative care support for kids in early cancer trials
This study tests adding palliative care—extra comfort and quality-of-life support—for children and young adults being considered for early-phase cancer trials. It involves patients, their families, and their doctors.
Phoenix, ArizonaAges birth–25 years - NCT07689656RecruitingPhase 1/Phase 2
PET imaging study for prostate cancer using a new tracer
This trial tests a new radioactive tracer called ELI421 to see how well it works for PET imaging in people with prostate cancer. It may help doctors find cancer more clearly.
Wuhan, HubeiAges 18–80 - NCT07689630RecruitingPhase 3
Antibody to prevent GVHD in half-matched stem cell transplant
This study is testing whether giving a special antibody (anti-CD25) before a half-matched stem cell transplant can prevent a common side effect called graft-versus-host disease (GVHD), where donor cells attack your body. It is for people with blood cancers who are getting this type of transplant.
Wuhan, HubeiAges 18–75 - NCT07689019Recruiting
Heat and electrical stimulation for head and neck cancer recovery
This study tests whether applying far infrared rays (a type of heat) or mild electrical pulses to the skin can help improve short-term recovery in people with head and neck cancer who are receiving chemotherapy and radiation together. It aims to see if these treatments can reduce side effects or improve quality of life.
Hualien City, Hualien CountyAges 30–85 - NCT07688915Recruiting
High-intensity laser vs. steroid injection for chronic back and leg pain from a herniated disc
This study compares two treatments for long-lasting low back and leg pain caused by a herniated disc: high-intensity laser therapy and a steroid shot near the spine. Researchers want to see which option works better to reduce pain.
AnkaraAges 18–65 - NCT07696936Recruiting
Robot vs manual arm artery brain scan trial
This trial tests if a robot can help perform a brain artery scan through the wrist as safely and effectively as the standard manual method. It might be an option if you need a detailed look at blood vessels in your brain.
Shijiazhuang, HebeiAges 18–80 - NCT07692152RecruitingPhase 3
Immunotherapy vs. chemo for MS anal cancer trial
This trial tests sintilimab (a type of immunotherapy) against mitomycin plus chemotherapy with radiation for anal cancer that hasn't spread. It aims to find a better treatment with fewer side effects.
Beijing, Beijing MunicipalityAges 18–75 - NCT07692035Recruiting
AI teaching tool for new ICU residents
This trial studies whether a new AI teaching tool helps ICU residents learn more effectively during their rotation. You'll use the AI tool on a regular device and complete short check-ins over 2 weeks.
Beijing, Beijing MunicipalityAges 18–40 - NCT07690345Recruiting
Fungal status and outlook in allergic bronchopulmonary aspergillosis
This study looks at how the presence of fungus in lung samples relates to the long-term outlook for people with allergic bronchopulmonary aspergillosis (ABPA). It aims to help doctors better understand the disease and guide treatment.
Jinan, ShandongAges 18 years+ - NCT07690254Recruiting
Brain monitor for emergency intubation
This trial uses a special brain activity sensor to see if it helps doctors during emergency breathing tube placement. It may help understand how patients respond to the procedure.
AntalyaAges 18 years+ - NCT07689760Enrolling by invitation
Ai tool to predict heart failure hospital visits
This study uses a smartphone app to track your heart failure and predict when you might need to go to the hospital. It aims to help you stay healthier and avoid urgent hospital stays.
EnschedeAges 18 years+ - NCT07690813Recruiting
AI model to predict nearsightedness with a non-dilated eye exam
This study uses an AI model to predict your nearsightedness prescription using a quick, non-dilated eye exam instead of the usual dilated exam. If you are between 18 and 60, have nearsightedness, and no major eye surgeries or conditions, you may be a good fit.
JiangxiAges 18–47 - NCT07690267Recruiting
Continuous vital sign monitoring in a surgical ward
This trial tests if keeping a close watch on vital signs like heart rate and breathing using wearable sensors can help spot problems earlier in people recovering from stomach or bowel surgery. It aims to make the recovery safer and catch any complications sooner.
Lørenskog, AkershusAges 18 years+ - NCT07689643RecruitingEarly Phase 1
Radioactive drug plus immunotherapy for FAP-positive lung cancer
This trial tests a new treatment that uses a radioactive medicine called [177Lu]Lu-RTX-2358 combined with immunotherapy (a type of drug that helps your immune system fight cancer). It is for people with advanced non-small cell lung cancer whose tumors have a specific marker called FAP.
Wuhan, HubeiAges 18 years+
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,202 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.